Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Study to Evaluate the Incidence of Skeletal Related Events In Prostate Cancer Patients Undergoing Androgen Deprivation Therapy (ADT).

NCT00632905 is registered in ClinicalTrials.gov with CMX Research as lead sponsor.

NCT NCT00632905
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00632905 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Study to Evaluate the Incidence of Skeletal Related Events In Prostate Cancer Patients Undergoing Androgen Deprivation Therapy (ADT).
Lead sponsor
CMX Research
Phase
Observational
Overall status
Completed
Start date
September 30, 2007
Completion date
March 31, 2016
Enrollment
599 (actual)
Sites
40

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer